
|Videos|July 9, 2015
Basing Treatment on a Calculated Risk for Atherosclerosis
Karen J. McConnell, Pharm.D., FCCP, BCPS, talks about what we have learned about atherosclerosis treatment from the updated ACC/AHA 2014 guidelines.
Advertisement
Karen J. McConnell, Pharm.D., FCCP, BCPS, clinical pharmacy specialist in cardiology at the Kaiser Permanente of Colorado and associate professor at the Skaggs School of Pharmacy (University of Colorado), talks about what we have learned about atherosclerosis treatment from the updated ACC/AHA 2014 guidelines.
This video was recorded at APhA’s Annual Meeting and Exposition in March 2015.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
CMS Announces 15 Drugs for Third Cycle of Medicare Drug Price Negotiation Program
2
Immuneering Panel & CEO Insights: Atebimetinib Raises the Bar for Survival and Quality of Life in Pancreatic Cancer
3
Centanafadine for Treatment of ADHD in Children, Adolescents, and Adults Accepted By FDA for Priority Review
4
January 2026 Product Updates
5



















